The pharmacogenetics data schema has been modified to accommodate info on star alleles from PharmGKB.
Two fields have been added to the schema (and need to be visualised in widget)
This is an example of how CYP2C9*2 and warfarin is represented:
-RECORD 0----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
datasourceId | pharmgkb
datasourceVersion | 2024-01-05
datatypeId | clinical_annotation
directionality | Decreased function
drugFromSource | warfarin
drugFromSourceId | CHEBI_10033
evidenceLevel | 1A
genotype | *2
genotypeAnnotationText | The CYP2C9*2 allele is assigned as a decreased function allele by CPIC. Patients with CYP2C9*2 in combination with another normal function allele, a decreased function allele, or a no function allele may have increased risk of bleeding when treated with warfarin as compared to patients with two normal function alleles. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence the risk of warfarin-induced bleeding.
genotypeId | NULL
haplotypeFromSourceId | PA165816543
haplotypeId | CYP2C9*2
literature | [29432897, 10509530, 31186542, 29432897, 17653141, 17653141, 17653141, 17653141, 17653141, 18756910, 24503627, 24503627, 11926893, 10509530, 18574025, 24503627, 24503627, 24474498, 25001883, 25001883, 23932037, 23932037, 23774101, 23104259, 23104259, 25521356, 25521356, 24602049, 25769357, 25858232, 14676821, 17955230, 18690342, 22571356, 19297219, 23602689, 21148049, 25244877, 15714076, 23348161, 18570163, 26777610, 27488176, 27581200, 28033245, 28033245, 28689179]
pgxCategory | toxicity
phenotypeFromSourceId | MP_0001914
phenotypeText | Hemorrhage
studyId | 1447672988
targetFromSourceId | ENSG00000138109
variantFunctionalConsequenceId | NULL
variantRsId | NULL
From a FE prospective, we will need to add one column to the Pharmacogenetics widget, named star allele.
This column will be placed between the rsID and genotype ID columns in target page widget and drug page widget.
star allele column with be populated with the haplotypeId field.
Field will be hyperlinked with this link: https://www.pharmgkb.org/haplotype/{haplotypeFromSourceId}
@chinmehta please let me know if you need more info
Following up from this data task - https://github.com/opentargets/issues/issues/3164.
The pharmacogenetics data schema has been modified to accommodate info on star alleles from PharmGKB. Two fields have been added to the schema (and need to be visualised in widget)
This is an example of how CYP2C9*2 and warfarin is represented:
From a FE prospective, we will need to add one column to the Pharmacogenetics widget, named
star allele
. This column will be placed between thersID
andgenotype ID
columns in target page widget and drug page widget.star allele column with be populated with the
haplotypeId
field. Field will be hyperlinked with this link:https://www.pharmgkb.org/haplotype/{haplotypeFromSourceId}
@chinmehta please let me know if you need more info